Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma

16 Dec 2016

Abstract excerpt

Aetiologically linked to HPV infection, malignancies of the anal canal have substantially increased in incidence over the last 20 years. Although most anal squamous cell carcinomas (SCCs) respond well to chemoradiotherapy, about 30% of patients experience a poor outcome, for undetermined reasons. Despite cumulative efforts for discovering independent predictors of overall survival, both nodal status and tumour...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cervical Cancer and HPV Research
Share to Colorectal and Anal Carcinomas
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27976366
DOI: 10.1002/path.4858

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinomaPMID 27976366Read ↗

A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine.Semantic proximity Read ↗

Transcriptomic Immune-related Signature Predictive of Chemoradiotherapy Response in Anal Squamous Cell CarcinomaSemantic proximity Read ↗

Transcriptomic Immune-related Signature Predictive of Chemoradiotherapy Response in Anal Squamous Cell CarcinomaSemantic proximity Read ↗

Molecular and genomic characterisation of a panel of human anal cancer cell lines.Semantic proximity Read ↗

Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention.Semantic proximity Read ↗

Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.Semantic proximity Read ↗

Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status.Semantic proximity Read ↗

Recent advances in the management of anal cancerSemantic proximity Read ↗

Molecular characterization of squamous cell carcinoma of the anal canalSemantic proximity Read ↗

Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwideSemantic proximity Read ↗

Genetic profile and functional proteomics of anal squamous cell carcinoma: proposal for a molecular classificationSemantic proximity Read ↗

HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer developmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.